Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

2′,2′-Difluorodeoxycytidine (gemcitabine, dFdC) and cis-diammine-dichloroplatinum (cisplatin, CDDP) are active agents against ovarian cancer and non-small-cell lung cancer (NSCLC). CDDP acts by formation of platinum (Pt)–DNA adducts; dFdC by dFdCTP incorporation into DNA, subsequently leading to inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Moorsel, C J A van, Pinedo, H M, Veerman, G, Bergman, A M, Kuiper, C M, Vermorken, J B, van der Vijgh, W J F, Peters, G J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363050/
https://www.ncbi.nlm.nih.gov/pubmed/10362105
http://dx.doi.org/10.1038/sj.bjc.6690452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363050/
https://www.ncbi.nlm.nih.gov/pubmed/10362105
http://dx.doi.org/10.1038/sj.bjc.6690452

Ejemplares similares